1. Introduction
===============

The Tibetan people have lived in Tibet (Xizang), Yunnan, Sichuan, Gansu, Qinghai and surrounding areas for many centuries. They have developed the Tibetan medical system based on the theory of "Four Tantras" (*rgyud bzhi* in the Tibetan language) and Tibetan medicine is still being used to treat various ailments in both urban and rural areas \[[@B1-toxins-07-00138],[@B2-toxins-07-00138]\].

As one of the most famous and important ethnomedicines in China, the Tibetan medicine has a history of more than 2500 years and was originated during the pre-Buddhist era when the Tibetan region was ruled under the Kingdom of *Zang Xung* (*Xiang Xiong*, *Shang Shung* or *Zhang Zhung*). The Tibetan medicine, called *Sowa Rigpa* in the Tibetan language, is still effective and widely used, even though the western and traditional Chinese medicinal systems have been practiced for several decades in the Tibetan areas.

The earliest treatments included natural herbal remedies and ritual practices. When the shamans presented their superstitious worship rituals to treat disorders, they used herbal medicines in the forms of poultices and wraps, especially for wounds \[[@B3-toxins-07-00138]\]. Living in the high elevation area with steep mountains, the Tibetan people would easily suffer from falls, fractures or other accidents. It became a priority to stop the pain when the shaman practiced their treatments. The pain-alleviation remedies normally contained toxins. Under the guidance of theories of traditional Tibetan medicine, the application of poisonous medicinal plants for some difficult diseases and severe acute diseases were evolved for thousands of years. The Tibetan healers still collect and prepare various poisonous plants for these remedies.

In Tibetan areas, poisonous plants are widely distributed from valleys to alpines, and from forests to meadows. Poisonous plants used in Tibetan medicine cover a large range of families, such as Polygonaceae (e.g., *Rheum*), Ranunculaceae (*Aconitum* and *Dalphinium*), Papaveraceae (*Meconopsis* and *Papaver*), Euphorbiaceae (*Euphorbia*), Thymelaeaceae (*Daphne*, *Stellera* and *Wikstroemia*), Fabaceae (*Oxytropis*), Loganiaceae (*Strychnos*), Asteraceae (*Liguraria* and *Saussurea*), Solanaceae (*Anisodus*, *Datura* and *Hyoscyamus*), Araceae (*Arisaema*), Liliaceae (*Veratrum*) and many others \[[@B4-toxins-07-00138],[@B5-toxins-07-00138],[@B6-toxins-07-00138]\]. Most of these plants contain toxic constituents with biological activities.

2. Representatives of Poisonous Plants in Tibetan Medicine
==========================================================

Based on the literature \[[@B4-toxins-07-00138],[@B5-toxins-07-00138],[@B6-toxins-07-00138]\], we propose that the following four species are representatives of the commonly used poisonous plants in Tibetan medicine: *Aconitum* *pendulum* (Ranunculaceae), *Strychnos nux-vomica* (Loganiaceae), *Datura stramonium* (Solanaceae) and *Anisodus tanguticus* (Solanaceae) ([Figure 1](#toxins-07-00138-f001){ref-type="fig"}). Botanical and ethnopharmacological aspects of these four species are summarized in this review.

2.1. Aconitum pendulum
----------------------

*Aconitum* is a large genus with more than 400 species, distributed in the temperate regions of the north hemisphere. There are 211 species in China, of which 166 are endemic to the country \[[@B7-toxins-07-00138]\]. Most of the Chinese *Aconitum* species are found in Sichuan, Yunnan and Tibet \[[@B7-toxins-07-00138],[@B8-toxins-07-00138],[@B9-toxins-07-00138]\].

In China, 76 *Aconitum* species have been used as herbal medicine and ethnomedicine. Most *Aconitum* species are very poisonous although the aconite roots of a few species have been consumed as root vegetables in China for a long time \[[@B10-toxins-07-00138],[@B11-toxins-07-00138]\]. They are mainly used in treating plaque, sepsis, intoxication, cold- and immune suppression-induced ailments, rheumatoid arthritis, and various types of pain, such as migraine, swelling caused by trauma and fracture, and facial paralysis. Pharmacologically, they can be developed as analgesic, anti-rheumatic and anti-arrhythmic agents. The key obstacle for their extensive medical utilization may be attributed to their extremely high toxicity \[[@B12-toxins-07-00138]\].

![The most important toxic alkaloids from representatives of Tibetan poisonous medicine.](toxins-07-00138-g001){#toxins-07-00138-f001}

In Tibetan medicine, at least 15 species (taxa, including varieties) of *Aconitum* have been used for a long time \[[@B4-toxins-07-00138],[@B5-toxins-07-00138],[@B8-toxins-07-00138],[@B9-toxins-07-00138],[@B10-toxins-07-00138]\]. They are divided into three ethnotaxa categorized by their color and toxicity of caudices, namely *Bang-Ga*, *Bang-Ma* (or *Bang-Se*), and *Bang-Na* in the Tibetan language ([Table 1](#toxins-07-00138-t001){ref-type="table"}).

Among these 15 *Aconitum* species used in Tibetan medicine, *Aconitum* *pendulum* Busch is the most important and commonly used one, which was named *Manqin* in Tibetan or *Xueshang Yizhihao* in Chinese. The medicinal part is the dried caudex. *Manqin* is widely used in prescriptions for treating ankle pains, arthritis, traumatic injuries, influenza, blast epidemic, furuncle carbuncle and tumors \[[@B5-toxins-07-00138]\]. *Manqin's* botanical description is: Caudex obconical. Stem 26--100 cm. Proximal cauline leaves withered at anthesis, petiole 4--5 mm; leaf blade broadly ovate, 3.4--5.5 × 4.5--5.5 cm, both surfaces glabrous, 3--5-sect. Inflorescence 6--20 cm, 8--35-flowered; rachis and pedicels densely spreading yellow pubescent. Pedicels 2--6 mm, distally with 2 bracteoles. Sepals yellow, usually greenish, sometimes blue. Petals glabrous or sparsely pubescent; limb *ca*. 8 mm. Stamens glabrous or sparsely pubescent; filaments entire. Carpels 5, glabrous or ovary spreading pubescent. Seeds *ca*. 3 mm. Flowering from July to September. Growing in grassy slopes, forest margins; 2800--4500 m above sea level in southwest China \[[@B6-toxins-07-00138]\].
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###### 

*Aconitum* species used in Tibetan medicine.

  Category in Tibetan Medicinal System                   Scientific Name                                          Distribution and Origin   Toxicity
  ------------------------------------------------------ -------------------------------------------------------- ------------------------- ----------
  *Bang-Ga* (with white caudices)                        *Aconitum naviculare* (Brühl) Stapf                      Tibet; Bhutan, NE India   Low
  *Aconitum tanguticum* (Maxim.) Stapf                   SW & W China                                             Low                       
  *Bang-Ma* or *Bang-Se* (with red or yellow caudices)   *Aconitum brunneum* Hand.-Mazz.                          SW & W China              Low
  *Aconitum pulchellum* Hand.-Mazz.                      SW China; Bhutan, NE India, Myanmar                      Low                       
  *Aconitum pulchellum* var. *racemosum* W. T. Wang      Yunnan                                                   Low                       
  *Bang-Na* (with black caudices)                        *Aconitum acutiusculum* var. *aureopilosum* W. T. Wang   Yunnan                    High
  *Aconitum brachypodum* Diels                           Sichuan, Yunnan                                          High                      
  *Aconitum* *bracteolosum* W. T. Wang                   Yunnan                                                   High                      
  *Aconitum dolichorhynchum* W. T. Wang                  Yunnan                                                   High                      
  *Aconitum flavum* Hand.-Mazz.                          SW & W China                                             High                      
  *Aconitum forrestii* Stapf                             SW China                                                 High                      
  *Aconitum gezaense* W. T. Wang et L. Q. Li             Yunnan                                                   High                      
  *Aconitum kongboense* Lauener                          SW China                                                 High                      
  *Aconitum pendulum* Busch                              SW & W China                                             High                      
  *Aconitum sungpanense* Hand.-Mazz.                     SW & W China                                             High                      

Processing is necessary in Tibetan ethnomedicine, especially for poisonous crude drugs. Before the caudices of *Aconitum* *pendulum* are used in medicine, they are soaked in water for 3--4 days, then cooked in boiling water for 4--6 h, followed by cutting into slices and drying. The processed caudices are still very poisonous, and can only be taken under the guidance of knowledgeable Tibetan healers.

2.2. Strychnos nux-vomica
-------------------------

The genus *Strychnos* L., with about 190 species, is distributed in the tropics and subtropics. Only 11 species are found in China. Most species in the genus are medicinal and poisonous \[[@B13-toxins-07-00138]\]. Two *Strychnos* species, *S. nux-vomica* and *S. wallichiana* Steudel ex A. de Candolle (*S*. *pierriana* A. W. Hill), have been used in Tibetan medicine. *Strychnos nux-vomica* (called *Tumdgha* in Tibetan) is the most important medicinal plant in the genus although it is a domesticated species in China. Its seeds, as the *materia medica*, are mainly imported from India.

The botanical description of *Strychnos nux-vomica* L. is: Trees 25 m tall. Petiole 0.5--1.5 cm; leaf blade 5--18 × 4--12.5 cm, papery, basal veins 3--5. Thyrses axillary, 3-6 cm; peduncle puberulent; bracteoles pubescent. Flowers 5-merous. Pedicel puberulent. Calyx lobes ovate. Corolla greenish white to white, salverform, *ca*. 1.3 cm; tube longer than lobes; lobes narrowly ovate, *ca*. 3 mm. Stamens inserted at mouth or corolla tube; filaments very short; anthers elliptic, *ca.* 1.7 mm. Pistil 1--1.2 cm. Ovary ovoid. Style to 1.1 cm; stigma capitate. Berries orange when ripe, globose, 2--4 cm in diam., 1--4-seeded. Seeds orbicular to elliptic, 2--4 cm wide. Flowering in spring to summer. The seeds are used as medicine, which are very poisonous \[[@B13-toxins-07-00138]\].

The *Strychnos nux-vomica* seeds must be processed before use in medicine. The major processing methods include cooking with tofu, stir-frying with soil or sands, boiling with vinegar, roasting, cauterizing with *Ephedra* or licorice (*Glycyrrhiza uralensis*), and others \[[@B14-toxins-07-00138]\]. The seeds are commonly used to treat traumatic injuries, pains, anaesthesia, paralysis, and tumors by traditional Tibetan healers.

2.3. Datura stramonium
----------------------

The genus *Datura* with 11 species originated from the Americas but is now widely distributed in the world. There are only 3 species in China, all of which are medicinal and poisonous \[[@B15-toxins-07-00138]\].

The botanical description for *Datura stramonium* L. (commonly named *Mantuoluo*) is briefly summarized here: Herbs annual, 0.5--1.5 m tall. Stems often dark violet. Petiole 2--6 cm; leaf blade 5--20 × 4--l5 cm, veins 4--6 pairs. Flowers erect. Pedicel *ca.* 1 cm. Calyx tubular, 4--9 cm. Corolla white, yellowish, or pale purple, funnelform, 14--20 cm; limb 6--10 cm in diam. Anthers 1--1.2 cm. Capsules *ca*. 3 cm in diam. Seeds pale brown, *ca.* 3 mm in diam. Flowering and fruiting in March---December. It grows on grassy and sunny slopes 1200--2100 m above sea level, near houses, or cultivated for ornamental or medicinal purposes. *Datura stramonium* is very common in southern and southwestern China \[[@B15-toxins-07-00138]\].

The whole plant, especially its seed, is toxic. The flowers are used as an anaesthetic. The seeds are used to treat ankle pains, asthma, cough, gastric convulsion, and traumatic injuries.

2.4. Anisodus tanguticus
------------------------

There are only four species in the genus *Anisodus*, and all species are found in China \[[@B15-toxins-07-00138]\]. Among these plants, *Anisodus tanguticus* (*Tangchong* in Tibetan language) is the most important species in Tibetan medicine.

The botanical characteristics of *Anisodus tanguticus* (Maxim.) Pascher is as follows: Herbs perennial, 40--100 cm tall. Roots stout. Petiole 1--3.5 cm; leaf blade 8--20 × 2.5--9 cm. Flowers nodding or erect; pedicel 1.5--8 cm. Calyx 2.5--4 cm. Corolla purple or dark-purple, sometimes pale yellow-green, resembling calyx in shape, 2.5--3.8 cm. Stamens less than half as long as corolla; filaments *ca*. 0.8 mm; anthers oblong, 5--6 mm. Style 1.2 cm. Fruiting pedicel 6--8 cm, erect. Fruiting calyx *ca*. 6--7.5 cm. Capsule *ca*. 2 cm in diam. Flowering in May--June, and fruiting in July--August. It grows on sunny grassy slopes; 2000--4400 m, mainly distributed in Gansu, Qinghai, NW and SW Sichuan, E Tibet, NW Yunnan, and Nepal \[[@B15-toxins-07-00138]\].

The local Tibetan healers use the roots of *Anisodus tanguticus* to treat pains, ulcers, colitis, gallstone, traumatic injuries, catagma and hemorrhage. In autumn or winter, they collect roots and cut them into slices for drying. Because of high toxicity, only a small amount of *Anisodus tanguticus* roots can be used externally.

3. Chemical Constituents of Important Poisonous Plants in Tibetan Medicine
==========================================================================

In recent years, the chemical constituents of these representative poisonous plants in Tibetan medicine have been studied. In *Aconitum pendulum*, alkaloids, steroids and glycosides have been isolated and determined \[[@B16-toxins-07-00138],[@B17-toxins-07-00138],[@B18-toxins-07-00138],[@B19-toxins-07-00138],[@B20-toxins-07-00138]\]. Alkaloids, iridoids and fatty acids were isolated from *Strychnos nux-vomica* \[[@B21-toxins-07-00138],[@B22-toxins-07-00138],[@B23-toxins-07-00138]\]. *Datura stramonium* is rich in alkaloids, flavanoids, withanolides as well as sesquiterpenes \[[@B24-toxins-07-00138],[@B25-toxins-07-00138],[@B26-toxins-07-00138],[@B27-toxins-07-00138]\]. The alkaloids have also been extracted from *Anisodus tanguticus* \[[@B28-toxins-07-00138]\]. Although numerous compounds have been isolated from these plants, alkaloids and their derivatives are generally considered as the key toxic and medicinal constituents.

3.1. Alkaloids from Aconitum pendulum
-------------------------------------

*Aconitum* species are rich in diterpenoid alkaloids, a group of highly toxic and medicinal constituents, which have been widely studied for their complex structures, thought-provoking chemistry, and noteworthy bioactivities \[[@B29-toxins-07-00138]\]. Based on the structure of diterpenoid alkaloids (DAs) isolated from *Aconitum*, they are commonly divided into three skeletal types: C18, C19 and C20 alkaloids \[[@B12-toxins-07-00138],[@B30-toxins-07-00138]\] ([Figure 2](#toxins-07-00138-f002){ref-type="fig"}), of which C18-diterpenoid alkaloids are the major compounds.

![Main skeletal types of diterpenoid alkaloids in *Aconitum*.](toxins-07-00138-g002){#toxins-07-00138-f002}

![Chemical structures of alkaloids isolated from *Aconitum pendulum*.](toxins-07-00138-g003){#toxins-07-00138-f003}

Recently, some DAs have been isolated from *A. pendulum*. Wang *et al.*, obtained three new C19-nor-diterpenoid alkaloids from the roots of *A. pendulum*, and named them *N*-deethyl-3-acetylaconitine (**1**), *N*-deethyldeoxyaconitine (**2**) and secoaconitine (**3**) \[[@B17-toxins-07-00138]\]. In addition, they isolated aconitine (**4**), deoxyaconitine (**5**), 3-acetylaconitine (**6**), neoline (**7**), 15-α-OH-neoline (**8**), benzoylconitine (**9**), polyschistine A (**10**), polyschistine D (**11**), benzoyldeoxyaconitine (**12**) and aconine (**13**) from 95% EtOH extract of its roots \[[@B18-toxins-07-00138]\] ([Figure 3](#toxins-07-00138-f003){ref-type="fig"}). Actually, as early as 1997, 10 alkaloids were isolated from the roots of *A. pendulum*, including 2-hydroxydeoxyaconitine (**14**), 12-epiacetyldehydrolucidusculline (**15**), 12-epiacetyldehydronapelline (**16**), dehydrolucidusculline (**17**) and dehydronapelline (**18**). 12-epidehydronapelline (**19**) and compounds **10** and **14** were new alkaloids \[[@B19-toxins-07-00138]\] ([Figure 3](#toxins-07-00138-f003){ref-type="fig"}).

In these alkaloids isolated from *A.* *pendulum*, aconitine has attracted the most attention for its high toxicity and wide range of bioactivities. It is a diester diterpenoid alkaloid, sharing the common C19-norditerpenoid skeleton. Structure-activity relationship research indicated that its high toxicity is attributed to the acetyl group at C8, the hydroxyl group at C13, 4 methoxyl groups at C1, C6, C16 and C18, and the benzoylester group at C14 \[[@B31-toxins-07-00138]\]. It needs heat-processing with boiling or steaming for the raw *A. pendulum* caudices before they are used in Tibetan medicine prescriptions. During the heat-processing, some of the aconitine alkaloids of diester-type are converted into benzoylaconines or aconines, which have lower toxicity compared to aconitine \[[@B31-toxins-07-00138],[@B32-toxins-07-00138]\] ([Figure 4](#toxins-07-00138-f004){ref-type="fig"}).

![Change of aconitine during heat-processing.](toxins-07-00138-g004){#toxins-07-00138-f004}

3.2. Alkaloids in Strychnos nux-vomica
--------------------------------------

The seeds of *Strychnos nux-vomica* are called *Maqianzi* in Chinese folk medicine, and *Tumdgha* in Tibetan medicine. They are commonly used for anaesthesia and treating traumatic injuries, pains, paralysis, and tumors by traditional Tibetan healers. In 1971, it was shown that alkaloids were the major bioactive components of this plant \[[@B33-toxins-07-00138]\]. Since then, more and more alkaloids have been found in this species ([Table 2](#toxins-07-00138-t002){ref-type="table"}). These alkaloids are toxic, and strychnine is the most abundant and has the highest toxicity. Makarovsky *et al.* pointed out that only 30 to 120 mg strychnine could kill a person \[[@B34-toxins-07-00138]\]. Due to the high toxicity, the seeds of *Strychnos nux-vomica* must be processed before clinical practice. During processing, the toxic alkaloids are converted into their isoforms or nitrogen oxidation derivatives, which are more or equally as potent and less toxic than their parent alkaloids \[[@B35-toxins-07-00138],[@B36-toxins-07-00138]\].
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Main alkaloids from *Strychnos nux-vomica*.

  No.   Alkaloids                                                        Tissue                   Reference
  ----- ---------------------------------------------------------------- ------------------------ --------------------------------------------------------------------------
  1     Strychnine                                                       Seeds, fruits            \[[@B37-toxins-07-00138],[@B38-toxins-07-00138],[@B39-toxins-07-00138]\]
  2     Brucine                                                          Seeds                    \[[@B37-toxins-07-00138],[@B38-toxins-07-00138]\]
  3     β-colubrine                                                      Seeds                    \[[@B37-toxins-07-00138],[@B38-toxins-07-00138]\]
  4     Icajine                                                          Seeds                    \[[@B37-toxins-07-00138],[@B38-toxins-07-00138]\]
  5     16-Hydroxy-α-colubrine                                           Seeds                    \[[@B37-toxins-07-00138]\]
  6     Brucine-*N*-oxide                                                Seeds                    \[[@B37-toxins-07-00138],[@B38-toxins-07-00138]\]
  7     Strychnine-*N*-oxide                                             Seeds                    \[[@B37-toxins-07-00138],[@B38-toxins-07-00138]\]
  8     Vomicine                                                         Seeds, fruits            \[[@B37-toxins-07-00138],[@B38-toxins-07-00138],[@B39-toxins-07-00138]\]
  9     Novacine                                                         Seeds                    \[[@B37-toxins-07-00138],[@B38-toxins-07-00138]\]
  10    Pseudostrychnine                                                 Seeds                    \[[@B37-toxins-07-00138],[@B38-toxins-07-00138]\]
  11    Pseudobrucine                                                    Seeds                    \[[@B37-toxins-07-00138]\]
  12    Isostrychnine                                                    Seeds                    \[[@B37-toxins-07-00138],[@B38-toxins-07-00138]\]
  13    Isobrucine                                                       Processed seeds, seeds   \[[@B37-toxins-07-00138],[@B38-toxins-07-00138]\]
  14    Isobrucine-*N*-oxide                                             Processed seeds, seeds   \[[@B37-toxins-07-00138],[@B38-toxins-07-00138]\]
  15    Isostrychnine-*N*-oxide                                          Processed seeds, seeds   \[[@B37-toxins-07-00138],[@B38-toxins-07-00138]\]
  16    2-Hydroxy-3-methoxystrychnine                                    Processed seeds          \[[@B37-toxins-07-00138]\]
  17    4-*N*-hydroxymethyl-strychnidin-17-acetic acid                   Seeds                    \[[@B40-toxins-07-00138]\]
  18    10,11-Dimethoxy-4-*N*-hydroxymethyl strychnidin-17-acetic acid   Seeds                    \[[@B40-toxins-07-00138]\]

![Main alkaloids from *Datura stramonium* and *Anisodus tanguticus*.](toxins-07-00138-g005){#toxins-07-00138-f005}

3.3. Alkaloids from Datura stramonium and Anisodus tanguticus
-------------------------------------------------------------

*Datura stramonium* and *Anisodus tanguticus* are important medicinal plants in the Solanaceae family in Tibetan medicine. Chemically, these two species are similar due to the abundant tropane alkaloids, which are characteristic in the Solanaceae family \[[@B41-toxins-07-00138]\].

Many tropane alkaloids have been found in *D. stramonium*, including hyoscyamine (**20**), anisodamine (**21**), scopolamine (**22**), atropine (**23**) and anisodine (**24**) \[[@B24-toxins-07-00138],[@B42-toxins-07-00138]\]. Recently, two novel amide alkaloids were separated from the alkaloidal fraction of *D. stramonium*. They are (*E*)-methyl 4-(3-(4-hydroxyphenyl)-*N*-methylacrylamido) butanoate (**25**) and 6,7-dimethyl-1-[d]{.smallcaps}-ribityl-quinoxaline-2,3(1H,4H)-dione-5\'-*O*-β-[d]{.smallcaps}-glucopyranoside (**26**). This was the first time that amide alkaloids were reported in this species \[[@B25-toxins-07-00138]\]. In *A. tanguticus*, hyoscyamine, anisodamine, scopolamine, tropine and cuscohygrine (**27**) were also isolated ([Figure 5](#toxins-07-00138-f005){ref-type="fig"}) \[[@B28-toxins-07-00138],[@B43-toxins-07-00138]\].

Although the tropane alkaloids of these two plants are similar, their characteristic alkaloids are different. The main toxic topane alkaloids are scopolamine in *D. stramonium*, and anisodamine in *A. tanguticus*. These two alkaloids are highly toxic and greatly diversified in their pharmacological activities.

4. Biological Activities of Chemicals from Important Poisonous Plants in Tibetan Medicine
=========================================================================================

Owing to the strong toxicity and crucial traditional medicinal value, various therapeutic effects of the representatives of poisonous plants and their compounds have been investigated. Most commonly reported biological activities are antinociceptive, improving cardiovascular, anti-inflammatory, anticholinergic, antispasmodic and anticancer properties. In this review, the main biological activities of aconitine, strychnine, scopolamine, and anisodamine are summarized.

4.1. Biological Activities of Aconitine
---------------------------------------

Aconitine, a C19 diterpenoid alkaloid, has been found to possess significant antinociceptive, cardiovascular beneficial and anti-epileptiform effects \[[@B31-toxins-07-00138],[@B44-toxins-07-00138],[@B45-toxins-07-00138]\]. Interestingly, these activities are mainly attributed to the effect of aconitine on voltage-gated Na^+^ channels.

In 1980, Catterall elucidated the antinociceptive mechanism for aconitine. Briefly, aconitine binds to site 2 of Na^+^ channels with high affinity, causing a sustaining activation of Na^+^ channels. Due to persistant Na^+^ channel activation, cells are depolarized by a permanent Na^+^ influx leading to inexcitability \[[@B46-toxins-07-00138]\]. Structure-activity relationship analysis showed that aconitine contributed the benzoyl ester side chain in C-14 to activate the Na^+^ channel \[[@B47-toxins-07-00138]\].

The initial research on aconitine toxicity focused on the cardiovascular-beneficial effect (arrhythmogenic), which is one of the factors contributing to fatal intoxications after ingesting *Aconitum*. Aconitine, binding with high affinity to the open state of Na^+^ channels at site-2, was found to delay the final repolarization of action potential of cardiac cells, leading to premature or triggered excitations \[[@B45-toxins-07-00138]\]. The final inexcitability might lead to heart arrest. The substituents including β-acetate on C-8, β-OH on C-13, α-aroyl on C-14, were considered as the key arrhythmogenic factors \[[@B45-toxins-07-00138]\].

Ameri's group has contributed much research on the inhibition of neuronal activity and anti-epileptiform activity of some diterpene alkaloids in rat hippocampal slices. Their studies showed that aconitine (1 μM) completely suppressed both epileptiform activity and normal neuronal activity, whereas lappaconitine (10 μM) and 6-benzoylheteratisine (10 μM) showed anti-epileptiform activity by sparing normal neuronal activity \[[@B44-toxins-07-00138]\]. Furthermore, the anti-epileptiform activity of these alkaloids was in line with the blockade of Na^+^ channels since Na^+^ channels were associated with the origin of the abnormal activity in epilepsy. In addition, anti-epileptic studies indicated that an aromatic substituent in these diterpene alkaloids is essential for their anti-epileptic activity \[[@B45-toxins-07-00138]\].

Dosage needs to be taken into consideration particularly in medicinal practice due to aconitine's potential toxicity. It has been shown that at the concentration of 30 nM, aconitine showed strong arrhythmogenic activity, an antinociceptive effect (ED~50~: 0.06 mg/kg) and high acute toxicity (LD~50~: 0.15 mg/kg) \[[@B47-toxins-07-00138]\]. The estimated lethal dose was 2 mg of aconitine, 1 g of the raw aconite plant or 5 mL of aconite tincture (an medicinal wine made by local people which can be absorbed via the skin into systemic circulation) \[[@B48-toxins-07-00138],[@B49-toxins-07-00138]\].

4.2. Biological Activities of Strychnine
----------------------------------------

Strychnine is an important indole alkaloid with a strychnan group, which has shown various biological activities.

Studies have been focused on the anti-tumor activities of strychnine. A few human cancer cell lines have been used to study the cytotoxic or anti-proliferative effects of strychnine. These cell lines, including SMMC-7721, HepG2 and RPMI-8226, exhibited growth inhibition at different levels when incubated with strychnine \[[@B50-toxins-07-00138],[@B51-toxins-07-00138],[@B52-toxins-07-00138]\]. In 2009, the *S. nux-vomica* root extract was shown to exhibit anti-proliferative and cytotoxic activity in RPMI-8226 cells, which was attributed to strychnine and brucine. The morphological assessment showed significant apoptosis of the cells. Cell cycle analysis revealed that these cells stayed at the sub-G0/G1 phase. Treated RPMI-8226 cells were also shown to have disrupted mitochondrial membrane potential and leaky mitochondrial cytochrome C \[[@B52-toxins-07-00138]\].

Angiogenesis is an important target of numerous chemo-defensive molecules, which control the angiogenic switch in pre-malignant tumors. Angiogenesis usually co-exists with inflammation in a variety of pathological states. The anti-tumor mechanism of strychnine is not completely known. In 2013, Saraswati and Agarwal studied the relationship between stychnine and inflammatory angiogensis in mice. They found that strychnine significantly reduced the main components of vascularization (haemoglobin content), macrophage recruitment (*N*-acetylglucosaminidase activity), and the levels of vascular endothelial growth factor (VEGF), tumor necrosis factor (TNF)-α and transforming growth factor (TGF-β). Their results indicated that strychnine could inhibit inflammatory angiogenesis via downregulation of VEGF, TNF-α and TGF-β in mice \[[@B53-toxins-07-00138]\]. Recently, the effects of strychnine on zebrafish embryos was studied, and it was shown that strychnine at 200 μmol/L induced apoptosis, and the ratio of Bax/Bcl-2 and p53 mRNA expression was significantly altered \[[@B54-toxins-07-00138]\]. These studies provided the basis for further exploring the potential pharmacological actions of strychnine.

Strychnine is also an analgesic and belongs to the group of analeptics. At low doses, strychnine can activate certain central nervous cells and stimulate vasomotor and respiratory centers. It can also induce convulsions by tetanizing activity \[[@B55-toxins-07-00138]\].

The effects of strychnine on the nervous system are mainly due to its extremely potent glycine antagonist property. It was reported that strychnine not only blocked postsynaptic receptors of the inhibitory neurotransmitter glycine, but also played a role in presynaptic action restraining release of the inhibitory neurotransmitter in the spinal cord and motoneurons. This action of strychnine results in unrestrained excitatory synapses, leading to a series of abnormal actions, including motor disturbance, increased muscle tone, hyperactivity of sensory, visual and acoustic perception. At high doses, strychnine will result in tonic convulsions and death directly through spinal paralysis or respiratory or cardiac arrest \[[@B55-toxins-07-00138]\].

Although strychnine is regarded as a highly toxic compound, a few significant bioactivities have been demonstrated. Its safety dose is 1--3 mg, which can increase spinal reflex with no effect on the respiratory and circulation systems. When the dose of strychnine is increased to 5--10 mg, the spinal reflex is greatly increased and muscles are tautened. More than 10 mg of strychnine may result in dyspnoea, anxiety, tonic convulsions and even death.

4.3. Biological Activities of Scopolamine
-----------------------------------------

Scopolamine, a tropane alkaloid, is the active ingredient responsible for analgesia, amnesia and motion sickness \[[@B56-toxins-07-00138]\]. It has an antagonistic action on muscarinic acetylcholine receptors in both peripheral and central nervous systems (CNS), exhibiting anticholinergic and spasmolytic properties \[[@B57-toxins-07-00138]\].

Traditionally, scopolamine was commonly used in the study of neuropsychopharmacology as a standard or reference compound for inducing dementia- and age-related cognitive deficits in healthy humans and animals \[[@B58-toxins-07-00138],[@B59-toxins-07-00138]\]. In 1974, it was first proposed that scopolamine simulated a few cognitive dysfunctions, like aging and dementia performance when administered to healthy volunteers \[[@B60-toxins-07-00138]\]. Subsequently, numerous articles reported on the cognitive impairment induced by scopolamine ([Table 3](#toxins-07-00138-t003){ref-type="table"}). To date, scopolamine has been employed as a common standard drug to estimate the activities of new substances such as imperatorin \[[@B61-toxins-07-00138]\], biperiden \[[@B62-toxins-07-00138]\], pioglitazone \[[@B63-toxins-07-00138]\], and to test models and methods designed to study cognitive dysfunction (e.g., Alzheimer's disease), in functional magnetic resonance imaging (fMRI) \[[@B64-toxins-07-00138]\], and acupuncture \[[@B65-toxins-07-00138]\].

As mentioned above, the bioactivity or toxicity mechanism of scopolamine may be attributed to its potent competitive muscarinic antagonist characteristics. Scopolamine can induce malfunction in the CNS's memory circuits and the regulation of the cholinergic neuronal pathway. Moreover, it down-regulates the expression of cAMP-response element-binding protein (CREB) in the brain and brain-derived neurotrophic factor (BDNF) \[[@B65-toxins-07-00138]\].

toxins-07-00138-t003_Table 3

###### 

Effects of scopolamine for cognitive impairment (Klinkenberg & Blokland, 2010 \[[@B59-toxins-07-00138]\]).

  Cognitive Impairment (CI)                    Specific Behavior                                       Pharmacological Activities Phenomenon               Reference
  -------------------------------------------- ------------------------------------------------------- --------------------------------------------------- ---------------------------------------------------
  Non-behavioral CI                            Pupil diameter, salivation and smooth muscle function   Dose-dependent increase in pupil size               \[[@B66-toxins-07-00138]\]
  Reduces salivation                           \[[@B67-toxins-07-00138]\]                                                                                  
  Induced gastrointestinal distress            \[[@B59-toxins-07-00138]\]                                                                                  
  Electroencephalogram                         Decreased low voltage fast activity                     \[[@B68-toxins-07-00138]\]                          
  Induced disturbances in gamma oscillations   \[[@B69-toxins-07-00138]\]                                                                                  
  Behavioral CI                                Locomotor activity and motor learning                   Increased locomotor activity                        \[[@B70-toxins-07-00138],[@B71-toxins-07-00138]\]
  Anxiety                                      lowered the number of transitions to the light side     \[[@B72-toxins-07-00138]\]                          
  Stimulus discrimination                      Implicated the (dorsal) hippocampus and cortex          \[[@B73-toxins-07-00138],[@B74-toxins-07-00138]\]   
  Attention                                    Impaired the maintenance of attention                   \[[@B75-toxins-07-00138]\]                          
  Learning and memory                          Interfere with short-term memory                        \[[@B76-toxins-07-00138]\]                          

4.4. Biological Activities of Anisodamine
-----------------------------------------

Anisodamine is isolated from *Anisodus tanguticus*, an important poisonous plant in Tibetan medicine. As a peripheral muscarinic antagonist, numerous pharmacologic activities, such as cognition improvement \[[@B77-toxins-07-00138],[@B78-toxins-07-00138]\], anti-inflammation \[[@B79-toxins-07-00138]\] and relieving spasms \[[@B80-toxins-07-00138],[@B81-toxins-07-00138]\], have been demonstrated.

As a natural muscarinic acetylcholine receptor (mAChR) antagonists, anisodamine has lower toxicity and weaker effect on the central nervous system than scopolamine, although both of them belong to tropane alkaloids and are considered as mAChR antagonists \[[@B77-toxins-07-00138]\]. Anisodamine has been reported to improve learning and memory in the avoidance response of rats after medial frontal cortex damage or acute cerebral ischemia and reperfusion \[[@B82-toxins-07-00138]\]. Wang *et al.* found that normal mice did not suffer from memory deficits when anisodamine was administered 11 times at 20 mg/kg \[[@B78-toxins-07-00138]\]. Recently, anisodamine administration resulted in no observable cognitive deficit, in contrast to scopolamine, and instead improved cognition, at a 40-fold higher dose than scopolamine \[[@B77-toxins-07-00138]\].

There is only one difference in the structures of anisodamine and scopolamine. At C6, anisodamine has an OH group, while there is an oxygen bridge between C6--C7 in scopolamine. Therefore, it is possible that the lipophilic solubility of anisodamine is decreased by the OH group at C6, reducing its permeability, which may lead to less cognitive impairment. Neuropsychopharmacological research demonstrated that anisodamine did not influence the formation of long-term potentiation (LTP) in the CA~1~ region of rat hippocampus but scopolamine did. In addition, the binding affinity of anisodamine to mice brain mAChR was much lower than that of scopolamine \[[@B77-toxins-07-00138]\]. These findings indicated that the poor blood brain barrier permeability of anisodamine contributed to its lower effectiveness on cognition impairment and LTP depression.

It was reported that anisodamine has the clinical applications to treat infectious shock, rheumatoid arthritis, glomerulonephritis, gastrointestinal colic and hemorrhagic necrotic enteritis \[[@B78-toxins-07-00138]\], indicating its strong impacts on inflammation. In 2009, Sprague-Dawley rats injected with lipopolysaccharide (LPS), α7nAChR-deficient mice and RAW264.7 cells were used to study the anti-shock effect of anisodamine. The results showed that the anti-shock effect was attributed to the inhibitory effect on tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) \[[@B83-toxins-07-00138]\]. Additionally, research from Zhou and colleagues demonstrated the anti-inflammation of anisodamine in collagen-induced arthritis in mice \[[@B84-toxins-07-00138]\].

Anisodamine has been widely used to relieve microvascular, intestinal and airway smooth muscle spasms. Recent reports showed that the proliferation and tracheal contractility of smoke extract-induced airway smooth muscle cell could be suppressed and reversed by anisodamine, revealing its effect on relieving airway spasms \[[@B80-toxins-07-00138]\]. Another investigation also demonstrated its similar effect on cardiac myocytes. Norby *et al.* declared that anisodamine could inhibit cardiac contractions and also inferred that the mechanism may be attributed to NO (nitric oxide) production and cholinoceptor antagonism \[[@B81-toxins-07-00138]\].

5. Conclusions
==============

Tibetan ethnomedicine has an important status both in traditional Chinese medicine and in the world medicine system. Poisonous plants, widely distributed in the Tibetan Plateau and neighboring areas, are significant sources of Tibetan medicine. In this review, four representative poisonous plants, *Aconitum* *pendulum*, *Strychnos nux-vomica*, *Datura stramonium* and *Anisodus tanguticus* are described in detail, including morphology of the plants, and the ethnopharmacology, toxicity, chemical constituents and bioactivity of the toxic compounds from these plants.

Although the representative plants possess various medicinal values, their high toxicity must be carefully evaluated. New methods and techniques should be adopted to improve their safety and availability. The process technologies and chemical conversions should be further studied. Although many compounds have been isolated from these plants, many other constituents need to be discovered. As for aconitine, strychnine, scopolamine and anisodamine, many of their significant bioactivities have been demonstrated. However, most of their modes of actions are still unknown. More studies are necessary to characterize their specific functions. In addition, synthetic strategies need to be considered to obtain specific compounds with higher bioactivities than their natural counterparts.
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